Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Goris, Nesya*" or (type exact bookEditor and editor="Goris, Nesya*")

Add to list
Evaluation of a modified Karnofsky score to assess physical and psychological wellbeing of cats in a hospital setting

Elien Taffin (UGent) , Dominique Paepe (UGent) , Miguel Campos (UGent) , Luc Duchateau (UGent) , Nesya Goris, Katrien De Roover (UGent) and Sylvie Daminet (UGent)

(2016) JOURNAL OF FELINE MEDICINE AND SURGERY. 18(11). p.913-920
Add to list
Antiviral treatment of feline immunodeficiency virus-infected cats with (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine

Elien Taffin (UGent) , Dominique Paepe (UGent) , Nesya Goris, Joeri Auwerx, Mariella Debille (UGent) , Johan Neyts, Isabel Van de Maele (UGent) and Sylvie Daminet (UGent)

(2015) JOURNAL OF FELINE MEDICINE AND SURGERY. 17(2). p.79-86
Add to list
Evaluation of the antiviral activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explants

Sarah Glorieux (UGent) , Annelies Vandekerckhove (UGent) , Nesya Goris, Xiaoyun Yang (UGent) , Lennert Steukers (UGent) , Gerlinde Van de Walle (UGent) , Siska Croubels (UGent) , Johan Neyts and Hans Nauwynck (UGent)

(2012) ANTIVIRAL RESEARCH. 93(2). p.234-238
Add to list
- PhD Thesis
Complexity of controlling foot-and-mouth disease

Nesya Goris

(2008)
Add to list
- Journal Article
- A1
Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative

Nesya Goris, T WILLEMS, VI DIEV, P MERKELBACH-PETERS, T VANBINST, Y VAN DER STEDE, HP KRAFT, VM ZAKHAROV, VV BORISOV, Hans Nauwynck (UGent) , et al.

(2008) VACCINE. 26(31). p.3870-3879

Academic Bibliography

Evaluation of a modified Karnofsky score to assess physical and psychological wellbeing of cats in a hospital setting

Antiviral treatment of feline immunodeficiency virus-infected cats with (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine

Evaluation of the antiviral activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explants

Complexity of controlling foot-and-mouth disease

Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative

Contents

Support

Contact